πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7629380

Antitumor agents

The Regents of the University of California Β· Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7622107

Recombinant intracellular pathogen immunogenic compositions and methods for use

The Regents of the University of California Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7622130

Methods and compositions for the non-surgical removal of fat

The Regents of the University of California Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7618936

Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)

The Regents of the University of California Β· Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7618627

Method of increasing radiation sensitivity by inhibition of beta one integrin

The Regents of the University of California Β· Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7608683

Stress proteins and peptides and methods of use thereof

The Regents of the University of California Β· Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7608449

Methods and compositions related to high-titer pseudotyped retroviruses

The Regents of the University of California Β· Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7601802

Cysteine-containing peptides having antioxidant properties

The Regents of the University of California Β· Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7598048

Screening methods for identifying agents that modulate output of a circadian pacemaker

The Regents of the University of California Β· Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7598341

Molecules that selectively home to vasculature of premalignant or malignant lesions of the

The Regents of the University of California Β· Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7595431

Mouse models of human prostate cancer

The Regents of the University of California Β· Granted Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7592016

Methods for preparing and using implantable substance delivery devices

The Regents of the University of California Β· Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7588912

Compositions and methods for preventing and treating anthrax diseases

The Regents of the University of California Β· Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7585868

Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists

The Regents of the University of California Β· Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7585842

Human kunitz-type inhibitor with enhanced antifibrinolytic activity

The Regents of the University of California Β· Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7582623

Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

The Regents of the University of California Β· Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7582736

Prostate cancer specific internalizing human antibodies

The Regents of the University of California Β· Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7579319

Methods for improving the structure and function of arterioles

The Regents of the University of California Β· Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7579188

Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment o

The Regents of the University of California Β· Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7575873

Reagents for diagnosing, imaging and treating atherosclerotic disease

The Regents of the University of California Β· Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7576175

Alpha-4 beta-1 integrin ligands for imaging and therapy

The Regents of the University of California Β· Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7572891

Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

The Regents of the University of California Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7569542

Anti-microbial targeting chimeric pharmaceutical

The Regents of the University of California Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7563457

Nanoparticle assembled hollow spheres

The Regents of the University of California Β· Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted